PPARγ Agonist-Loaded PLGA-PEG Nanocarriers as a Potential Treatment for Alzheimer’s Disease: In vitro and in vivo Studies [Corrigendum]

PPARγ Agonist-Loaded PLGA-PEG Nanocarriers as a Potential Treatment for Alzheimer’s Disease: In vitro and in vivo Studies [Corrigendum]

Silva-Abreu M, Calpena AC, Andrés-Benito P, et al. Int J Nanomedicine. 2018;13:5577–5590. In the published article, there was an error in Figure 6A on page 5585. The image for Rhod-NPs was duplicated by a mislabeling of the image files. A new image for Rhod-NPs has been updated...

Full description

Bibliographic Details
Main Authors:	Silva-Abreu M, Calpena AC, Andrés-Benito P, Aso E, Romero IA, Roig-Carles D, Gromnicova R, Espina M, Ferrer I, García ML, Male D
Format:	Article
Language:	English
Published:	Dove Medical Press 2023-07-01
Series:	International Journal of Nanomedicine
Subjects:	nanoparticle alzheimer’s disease blood brain barrier brain endothelium pioglitazone app/ps1 transgenic mouse.
Online Access:	https://www.dovepress.com/corrigendum-ppargamma-agonist-loaded-plga-peg-nanocarriers-as-a-potent-peer-reviewed-fulltext-article-IJN

Similar Items

PPAR Gamma Receptor: A Novel Target to Improve Morbidity in Preterm Babies
by: Suresh Victor, et al.
Published: (2023-10-01)

Thiazolidinediones play a positive role in the vascular endothelium and inhibit plaque progression in diabetic patients with coronary atherosclerosis: A systematic review and meta-analysis
by: Cheng Yuan Xue, et al.
Published: (2022-11-01)

Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization
by: Elena Sánchez-López, et al.
Published: (2018-03-01)

The Effect of Co-administration of Pioglitazone and Simvastatin on Insulin Resistance Parameters and PPAR.γ Expression in Insulin-resistant Rats
by: Gholam Abbas Mohammadi, et al.
Published: (2017-01-01)

Breaking and building the wall: the biology of the blood-brain barrier in health and disease
by: Annika Keller
Published: (2013-11-01)

Stabilization by Nano Spray Dryer of Pioglitazone Polymeric Nanosystems: Development, In Vivo, Ex Vivo and Synchrotron Analysis
by: Marcelle Silva-Abreu, et al.
Published: (2021-10-01)

Immunomodulatory dynamics in the porcine myometrium: global transcriptome analysis, including the effects of PPARγ ligands
by: Aleksandra Kurzynska, et al.
Published: (2024-12-01)

Cardiovascular protective effects of PPARγ agonists in hypothyroid rats: protection against oxidative stress
by: Yousef Baghcheghi, et al.
Published: (2022-08-01)

PPAR-gamma agonist pioglitazone recovers mitochondrial quality control in fibroblasts from PITRM1-deficient patients
by: Alessia Di Donfrancesco, et al.
Published: (2023-07-01)

A Possible Modulator of Vitiligo Metabolic Impairment: Rethinking a PPARγ Agonist
by: Federica Papaccio, et al.
Published: (2022-11-01)

Surface Functionalization of PLGA Nanoparticles to Increase Transport across the BBB for Alzheimer’s Disease
by: Laura Del Amo, et al.
Published: (2021-05-01)

Identifying molecular tags selectively retained on the surface of brain endothelial cells to generate artificial targets for therapy delivery
by: Giulia Maria Porro, et al.
Published: (2023-12-01)

The Role and Therapeutic Implications of Inflammation in the Pathogenesis of Brain Arteriovenous Malformations
by: Ashley R. Ricciardelli, et al.
Published: (2023-10-01)

PPARγ activation improved learning and memory and attenuated oxidative stress in the hippocampus and cortex of aged rats
by: Farimah Beheshti, et al.
Published: (2022-12-01)

The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function
by: Gray Elizabeth, et al.
Published: (2012-04-01)

Navigating Alzheimer’s Disease Mouse Models: Age-Related Pathology and Cognitive Deficits
by: Laura Maria De Plano, et al.
Published: (2024-11-01)

PPAR Gamma Agonist Leriglitazone Recovers Alterations Due to Pank2-Deficiency in hiPS-Derived Astrocytes
by: Paolo Santambrogio, et al.
Published: (2023-01-01)

Molecular Heterogeneity of the Brain Endothelium
by: Nada Alnaqbi, et al.
Published: (2023-04-01)

PEG-Free Polyion Complex Nanocarriers for Brain-Derived Neurotrophic Factor
by: James M. Fay, et al.
Published: (2022-06-01)

Pioglitazone enhances cisplatin’s impact on triple-negative breast cancer: Role of PPARγ in cell apoptosis
by: Qamraa Hamad Alqahtani, et al.
Published: (2024-05-01)

Amelioration of High Fructose Diet-Induced Insulin Resistance, Hyperuricemia, and Liver Oxidative Stress by Combined Use of Selective Agonists of PPAR-α and PPAR-γ in Rats
by: Mahmoud M. Farag, et al.
Published: (2020-04-01)

Material informatics-driven insights into brain cancer nanocarriers: A bibliometric comparison of PLGA vs. liposomes
by: Brilly Andro Makalew, et al.
Published: (2025-01-01)

Development and Validation of an HPLC–MS/MS Method for Pioglitazone from Nanocarriers Quantitation in Ex Vivo and In Vivo Ocular Tissues
by: Esther Miralles-Cardiel, et al.
Published: (2021-05-01)

Enhanced 3T3-L1 Differentiation into Adipocytes by Pioglitazone Pharmacological Activation of Peroxisome Proliferator Activated Receptor-Gamma (PPAR-γ)
by: Catarina Teixeira, et al.
Published: (2022-05-01)

Vasoactive Soluble Endoglin: A Novel Biomarker Indicative of Reperfusion after Cerebral Large-Vessel Occlusion
by: Axel Haarmann, et al.
Published: (2023-01-01)

Association between the simultaneous decrease in the levels of soluble vascular cell adhesion molecule-1 and S100 protein and good neurological outcomes in cardiac arrest survivors
by: Min-Jung Kim, et al.
Published: (2018-12-01)

Short-term exposure to JUUL electronic cigarettes can worsen ischemic stroke outcome
by: Ali Ehsan Sifat, et al.
Published: (2022-09-01)

A retrospective study on finding correlation of pioglitazone and incidences of bladder cancer in the Indian population
by: V Balaji, et al.
Published: (2014-01-01)

The association between pioglitazone consumption and incidence of bladder cancer in type II diabetic patients: a systematic review and meta-analysis of observational studies
by: Pantea Ramezannezhad, et al.
Published: (2023-03-01)

Cortistatin deficiency reveals a dysfunctional brain endothelium with impaired gene pathways, exacerbated immune activation, and disrupted barrier integrity
by: Julia Castillo-González, et al.
Published: (2023-10-01)

Exposure to nano-polystyrene during pregnancy leads to Alzheimer's disease-related pathological changes in adult offspring
by: Fengxu Wang, et al.
Published: (2025-01-01)

Lipid nanocarriers encapsulating herbal drugs for brain diseases therapy
by: Sara S. Gad, et al.
Published: (2023-06-01)

Effects of chronic treatment with metformin on brain glucose hypometabolism and central insulin actions in transgenic mice with tauopathy
by: Verónica Hurtado-Carneiro, et al.
Published: (2024-08-01)

Toxic oligomer species of amyloid-β in Alzheimer's disease, a timing issue
by: Sylvain E. Lesne
Published: (2014-11-01)

A Touchscreen Device for Behavioral Testing in Pigs
by: Will Ao, et al.
Published: (2022-10-01)

The Role of BAR Proteins and the Glycocalyx in Brain Endothelium Transcytosis
by: Diana M. Leite, et al.
Published: (2020-12-01)

Transcriptional Responses of In Vitro Blood–Brain Barrier Models to Shear Stress
by: Koji L. Foreman, et al.
Published: (2025-01-01)

Nano-encapsulated tanshinone IIA in PLGA-PEG-COOH inhibits apoptosis and inflammation in cerebral ischemia/reperfusion injury
by: Zhang Xin, et al.
Published: (2023-03-01)

PPARγ-Independent Side Effects of Thiazolidinediones on Mitochondrial Redox State in Rat Isolated Hearts
by: Matthias L. Riess, et al.
Published: (2020-01-01)

Nucleic acid delivery by ionizable nanocarriers for brain disease treatment
by: Ruru Xiong, et al.
Published: (2023-03-01)